Introduction {#S1}
============

Almost over one-third of the world's population is overweight or obese ([@B14]). This condition negatively affects the life quality, productivity, and costs with public health. One of the main aspects of this body weight regulation is feeding behavior ([@B57]) which involves neural networks such as the serotonergic (5HT) and dopaminergic (DA) systems ([@B45]). Several studies show that the disruption of those systems is strongly associated with increased food intake and/or preference for palatable food, which are important factors contributing for the onset of obesity ([@B77]). Gene expression of both 5HT and DA systems can be influenced by miRNAs ([@B40]; [@B64]), and in this case, they would be the key regulatory molecules in the comprehension of the pathophysiology of the feeding behavior.

MiRNAs are small non-coding RNAs with an average length of approximately 22 nucleotides ([@B4]). They regulate post-transcriptional gene expression by binding to the 3′UTR of mRNAs, some miRNAs also regulate the expression of another or several other miRNAs ([@B74]), and even themselves ([@B97]). Generally, miRNA specifically inhibit protein synthesis either by repressing translation or by inducing deadenylation and degradation of target mRNA ([@B4]) but were also reported to activate translation ([@B32]). Each miRNA has the capacity to target hundreds of diverse transcripts, and a single messenger can be modulated by several miRNAs, this represents a highly coordinated system and fine-tuned regulation of protein expression ([@B38]; [@B50]).

On the other hand, a healthy environment during the beginning of life is crucial for a proper development in mammals ([@B59]; [@B46] 2002). Maternal nutritional and emotional factors are critical during periconceptional and perinatal periods ([@B46]; [@B12]). Early life stress (ELS) experiences can lead to long-term neurobehavioral complications. Both pre-clinical and clinical studies identify the influence of ELS on the development of several psychiatric disorders, including perturbation of feeding behavior, eating disorders and obesity ([@B12]; [@B20]). Interestingly, the miRNAs are also sensible to ELS through several models, as showed on [Table 1](#T1){ref-type="table"}. In this context, this review brings a potential role of the miRNAs in the onset of obesity through modulation of 5HT and DA in response to ELS.

###### 

Influences of ELS on miRNA activity.

  **ELS model**                                                     **Subjects**                    **Region**                           **Outcome**                                                                                                                                                      **Authors**
  ----------------------------------------------------------------- ------------------------------- ------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------
  **Pre-clinical studies**                                                                                                                                                                                                                                                                                
  MS                                                                Rat                             Hippocampus                          Increased miR-16                                                                                                                                                 [@B3]
  MS                                                                Mice                            Cortical neurons                     Impaired response of miR-212 to the learning process on a cocaine conditioned place preference test                                                              [@B78]
  MS + CUS                                                          Rat                             NAcc                                 Increased miR-504                                                                                                                                                [@B94]
  MS                                                                Rat                             mPFC                                 Increased REST4                                                                                                                                                  [@B75]
  Morphine + Apnea + MS                                             Mice                            Hippocampus                          Decreased miR-204-5p, miR-455-3p, miR-448-5p, and miR-574-3p                                                                                                     [@B44]
  CUMS                                                              Rat                             Basolateral amygdala                 Increased rno-miR-124a                                                                                                                                           [@B89]
  Increased maternal care                                           Rat                             Hypothalamus                         increased rno-miR-488, rno-miR-144, and rno-miR-542-5p and decreased rno-miR-421 and rno-miR-376b-5p                                                             [@B79]
  Protein malnutrition                                              Mice                            Hypothalamus                         increased mmu-miR-187-3p, mmu-miR-369-3p and mmu-miR-132-3p                                                                                                      [@B6]
  Unpredictable maternal separation combined with maternal stress   Mice                            Sperm                                Changes in miRNA transmitted to F2 generation                                                                                                                    [@B24]
  Prenatal stress                                                   Rat                             Hippocampus                          Decreased hsa-miR-125b-1-3p                                                                                                                                      [@B11]
  **Clinical studies**                                                                                                                                                                                                                                                                                    
  Childhood maltreatment                                            both sexes                      Leukocytes                           Methylation changes in CpGs close to region coding miR-124-3                                                                                                     [@B55]
  Childhood abuse                                                   Men aged 45 years old           Whole blood                          Methylation changes in promoter region of 39 miRNAs                                                                                                              [@B67]
  Child abuse                                                       European adults of both sexes   Buccal mucosa cells                  Association between the polymorphism rs3125 of 5HT2A and brooding. This region is predicted to be targeted by miR-1270, miR-1304, miR-202, miR-539 and miR-620   [@B21]
  Childhood trauma                                                  Adult of both sexes             Blood cells                          Decreased hsa-miR-125b-1-3p                                                                                                                                      [@B11]
  Childhood trauma                                                  Adult both sexes                Human hippocampus progenitor cells   Decreased hsa-miR-125b-1-3p                                                                                                                                      [@B11]

ELS, early life stress; MS, maternal separation; CUS, chronic unpredictable stress; CUMS, chronic unpredictable mild-life stress; NAc, nucleus accumbens; mPFC, medial pre-frontal cortex; CpGs, methylated cytosines followed by guanine nucleotide sites.

Serotonin: Role on Feeding Behavior, Influences of ELS, and miRNA Regulation {#S2}
============================================================================

The 5HT system includes receptors, transporters and enzymes involved in the metabolism of serotonin (5-Hydroxytryptamine), and it regulates several functions in the organism as locomotors activity, body temperature, wake-sleep cycle, and feeding behavior ([@B39]; [@B52]). Regarding the control of eating behavior, serotonin has a well-established anorectic role through promotion of satiety. In the arcuate nucleus of the hypothalamus, serotonin acts in different ways; it acts on 5HT1B, promoting inhibition of neurons that produce neuropeptide Y (NPY) and the cocaine and amphetamine-related transcript (CART), which are orexigenic. It also acts on 5HT2C, promoting activation of neurons that produce pro-opiomelanocortin (POMC) and the peptide related to the agouti gene (AgRP), which are anorexigenic, thus promoting satiety signaling ([@B30]). In addition, recent studies also refer that serotonin has a role in the hedonic regulation of eating behavior. Receptors such as 5HT6 in areas of the mesocorticolimbic circuit have been associated with motivational feeding behavior ([@B15]). The impairments of the homeostasis of the serotonergic system are associated with disorders of eating behavior, usually associated with increased food intake, either by homeostatic or hedonic changes. In particular, the serotonergic system appears extremely sensitive to environmental changes during the development of the organism, and several studies have shown that ELS impairs the function of the 5HT system ([@B16]).

Models of ELS in animals are usually associated with deprivation of the mother--infant relationship, such as in maternal separation (MS) and early weaning (EW) models ([@B37]; [@B29]). Previous studies from our laboratory show that the MS disrupts the 5HT system. In middle aged females, it increases the 5HT1B gene expression in the hypothalamus, associated with decreased food intake ([@B17]), and in adult males, we observed a decreased action of fluoxetine on food intake ([@B18]). In addition, MS promotes decreased 5HT concentration in hypothalamus and amygdala of young animals, associated with increased palatable food intake ([@B16]). Together, these data suggest that MS alter the serotonergic system function, contributing to disorders of feeding behavior. On the other hand, we have been able to associate the EW with changes in gene expression of several components of the 5HT system in male and female rats, such as SERT, 5HT1B, and 5HT2C in hypothalamus and brainstem. Based on the patterns of expression in the brainstem and response to fenfluramine, we suggested a hypofunction of the serotonergic system in the EW animals ([@B70], [@B68],[@B69]). All these changes in the 5-HT system were accompanied by alterations on feeding behavior, which indicate that the 5HT system control of feeding behavior can be modulated by ELS, which can be directly linked to the onset of obesity.

Recently, studies have deepened about these compensatory changes and epigenetic modifications have been extensively investigated. In this respect, miRNAs have been shown to be important regulators y/o mediators of gene expression. In the case of depression, it is currently accepted that several miRNAs modulate the activity of the serotonergic system, but little is known about these regulators in the context of eating behavior. As far as we know, miR-16 is able to bind the SERT messenger ([Table 2](#T2){ref-type="table"}) and silence its expression in humans and animals ([@B5]; [@B48]; [@B65]; [@B63]). The relationship between miR-16 and SERT is even modulated by pharmacological antidepressant treatment and also alternative treatments as the electroacupuncture; besides different responses according to the affected brain area, these treatments improve the level of depressive behaviors, suggesting a highly specific regulation ([@B5]; [@B95]). SERT appears to be a key piece of regulation, as different miRNAs can modify its expression, as the mmu-miR-135 ([@B34]), rno-miR-18a-5p, rno-miR-34a-5p, rno-miR-135a-5p, rno-miR-195-5p, rno-miR-320-3p, rno-miR-674-3p, and rno-miR-872-5p ([@B98]). This relationship between miR-16 and SERT is interesting, since SERT activity is directly related to serotonergic signaling. SERT recaptures the remaining amount of serotonin from the synaptic clefts, and an increase in its activity may mean a decrease in serotonergic signaling. In depression, has been shown that decreased levels of miR-16 and elevated levels of SERT are associated with the pathology by promoting a reduction in serotonergic signaling. Drugs that block SERT activity and increase serotonin levels are used to treat this depressive behavior. Interestingly, the same drugs are used to treat obesity ([@B28]) as they also promote a reduction in food intake. This evidence gives a primary role to miR-16 that may also be a candidate to modulate SERT activity in the context of eating disorders.

###### 

Components of the serotonergic and dopaminergic systems and their regulatory-associated miRNAs.

  **Components**                                      **miRNAs**                                                                                                  **Authors**
  --------------------------------------------------- ----------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------
  **Serotonin or 5-Hydroxytryptamine (5HT) system**                                                                                                               
  SERT (SLC6A4/5HTT)                                  miR-16, miR-135, miR-18a-5p, miR-34a-5p, miR-135a-5p, miR-195-5p, miR-320-3p, miR-674-3p, and miR-872-5p.   [@B5]; [@B40]; [@B48]; [@B34]; [@B65]; [@B98]; [@B63]; [@B95]
  5HT1A                                               miR-16, miR-135, and miR-26a-2.                                                                             [@B41]; [@B88]
  5HT1B                                               miR-96                                                                                                      [@B35]
  5HT2A                                               miR-16                                                                                                      [@B90]
  5HT2C                                               miR-34                                                                                                      [@B1]
  5HT4                                                miR-103, miR-15b, and a mix containing miR-103, miR-15b, and miR-16                                         [@B85]
  5HT7                                                miR-29a                                                                                                     [@B81]
  **Dopamine (DA) system**                                                                                                                                        
  DRD1                                                miR-504, miR-105, miR-15a, miR-15b, miR-16 and miR-142-3p                                                   [@B73], [@B72]; [@B94]; [@B96]; [@B87]
  DRD2                                                miR-143, miR-200a, miR-504, has-miR-9 and miR-326                                                           [@B94], [@B93]; [@B64]; [@B23]; [@B86]; [@B43]; [@B82]
  DRD3                                                let-7d                                                                                                      [@B2]
  DAT                                                 miR-137 and miR-491                                                                                         [@B36]

SERT, solute carrier family 6 member 4 (SLC6A4/5HTT), serotonin transporter; 5HT1A, 5-Hydroxytryptamine receptor 1A; 5HT1B, 5-Hydroxytryptamine receptor 1B; 5HT2C, 5-Hydroxytryptamine receptor 2C; 5HT4, 5-Hydroxytryptamine receptor 4; 5HT7, 5-Hydroxytryptamine receptor 7; DRD1, dopamine receptor D1; DRD2, dopamine receptor D2; DRD3, dopamine receptor D3; DAT, dopamine transporter, solute carrier family 6 member 3 (SLC6A3).

In addition to SERT, miRNAs modulate the activity of other components of the serotonergic system ([Table 2](#T2){ref-type="table"}), such as 5HT1B, 5HT1A, 5HT4, 5HT2C, and 5HT7. The 5HT1B receptor is advised as a target of the miR-96 ([@B35]). 5HT1A seems to be targeted by miR-16, miR-135 ([@B41]), and has-miR-26a-2 ([@B88]). The 5HT4 receptor acquire decreased expression in response to miR-103, has-miR-15b and a mix containing hsa-miR-103, has-miR-15b and hsa-miR-16 ([@B85]). In addition, miR-34 appears to bind the receptor 5HT2C ([@B1]), hsa-miR-16 appears to reduce 5HT2A expression ([@B90]), and miR-29a decreases the expression of 5HT7 ([@B81]). The impairment of the activity of these receptors is associated with disrupted food intake either by homeostatic or hedonic mechanisms. 5HT1A, 5HT1B, and 5HT2C are strongly associated with satiety signaling, and several studies report that their disruption promotes increased food intake. On the other hand, 5HT4 is associated with hedonic modulation of food intake and obesity. Thus, the modulation of these receptors through miRNAs can also be associated with the onset of eating disorders leading to obesity.

Dopamine: Role on Feeding Behavior, Influences of ELS, and miRNA Regulation {#S3}
===========================================================================

The dopaminergic system, as well as the serotoninergic system, comprises a set of neurotransmitter, enzymes, receptors, and dopamine transporter (DAT). On the other hand, neurons that synthesize dopamine can be found in the brainstem and can be divided into three groups, which forms the Nigro Striatal system, the mesocorticolimbic system, and the mesocortical system ([@B51]). The principal role on feeding behavior is taken by the mesocorticolimbic system ([@B84]; [@B7]). Dopaminergic neurons are known to be involved in emotion-based behavior including motivation and reward ([@B54]). Therefore, in the context of the feeding behavior, this system is mainly related to the hedonic component of feeding, but evidences also point out that dopamine is a key component on hypothalamic regulation of the homeostatic eating behavior ([@B45]; [@B33]).

The DA system is sensible to ELS and its disruption is associated with several psychiatric disorders, such as eating disorders and obesity ([@B49]). Our previous study showed that DRD1 and DRD2 gene expression were increased in the brainstem of adult rats, accompanied by higher palatable food intake after MS ([@B19]). The MS also modulates the DA system in other brain areas, such as PLC, NAcc, and striatum, changing the density of immunoreactive fibers of TH, and the mRNA expression of DRD2, DRD1, and DRD5 ([@B42]). On the other hand, EW increases DRD1 mRNA expression in the hypothalamus and brainstem and DRD2 in the brainstem of middle-aged male rats ([@B69]). In all of these studies, disrupted patterns on feeding behavior are observed, indicating that alterations in the dopaminergic system can be one of the underlying mechanisms that lead to behavioral disorders.

Increased evidence points out that several components of the dopaminergic system are influenced by some miRNAs ([Table 2](#T2){ref-type="table"}). DRD1 appears to be regulated by miR-504 ([@B94]), rno-miR-105 ([@B96]), and for the cluster of hsa-miR-15a-5p, hsa-miR-15b-5p, and hsa-miR-16-5p, and mmu-miR-142-3p ([@B73], [@B72]). The expression of the DRD2 is modified by miR-143-3p ([@B82]), miR-200a ([@B86]), miR-504 ([@B94]), hsa-miR-9, and hsa-miR-326 ([@B64]; [@B93]; [@B23]; [@B43]). Both receptors, DRD1 and DRD2, are associated with control of food intake, either homeostatic or hedonic, in several areas of the brain ([@B84]; [@B33]) which indicates that its modulation through miRNAs can modulate the food intake. In addition, overexpression of let-7d is negatively correlated with the expression of DRD3 in the hippocampus of mice ([@B2]). The activity of the DRD3 is controversy in the context of food intake, but some evidences associate it with eating disorders and decreased food intake ([@B71]; [@B26]). The expression of DAT, the major controller of dopamine levels in the synaptic clefts, is post-transcriptionally regulated on cell culture of dopaminergic neurons by miR-137 and miR-491 ([@B36]). This transporter acts like SERT, reuptaking the dopamine from the synaptic cleft, so its function is extremely necessary to normal DA signalization, even in the context of eating behavior. On the other hand, the reduction of Dicer, a miRNA-processing ribonuclease III, in the ventral midbrain of DA neurons promotes changes in the miRNAs profile and altered the survival capacity of these dopaminergic neurons ([@B13]). Together, these evidences extended the susceptibility of the DA system to the regulation of miRNAs, which can lead to modulation of eating behavior and may be associated with eating disorders.

Perspectives: Role of the miRNAs on the Onset of Obesity Through 5HT and DA Systems' Disruption in the Context of ELS {#S4}
=====================================================================================================================

In addition to knowing that components of the 5HT and DA neurotransmission systems are susceptible to ELS, some evidence also shows that miRNAs have their expression and activity influenced by ELS, which is summarized in [Table 1](#T1){ref-type="table"}. Both, pre-clinical and clinical studies affirm that childhood trauma could be associated with the modulation of miRNA, as the case of the miR-16 and miR-504 which have their control of the serotonin and dopamine impaired by stress, with consequences such as depression, anhedonia, and body weight gain. However, more studies are needed to understand the full picture, specifically in the context of the control of the feeding behavior, which is directly involved in the development of obesity.

Conversely, both clinical and pre-clinical studies demonstrate that ELS is able to alter SERT activity ([@B83]; [@B76]; [@B70], [@B68]). Interestingly, differences in SERT activity are observed in obesity, both in humans and animals ([@B25]; [@B9]; [@B92]). For example, the density of SERT is reduced in obese humans ([@B25]; [@B9]) and increased in rats with abdominal obesity who were exposed to a diet rich in simple carbohydrates ([@B66]). In addition to being involved in the pathophysiology of obesity and being sensitive to ELS, several lines of evidence in the literature show that SERT is a target for miR-16 and propose an important role in regulating its activity ([@B5]). On the other hand, animal studies demonstrate that the 5HT1A receptor is also modulated by ELS ([@B10]; [@B56]) and has increased density in the hippocampus and hypothalamus of rats chronically submitted to a Westernized diet ([@B91]). Interestingly, 5HT1A is also the target of miR-16, which has its expression modulated by ELS ([@B3]). The receptor 5HT2A is, as well, modulated by ELS in animals and humans ([@B58]; [@B53]) and involved with the pathophysiology of obesity ([@B62]; [@B31]). Interestingly, the 5HT2A is also targeted by the miR-16 ([@B90]). From these observations, we believe that miR-16 is an excellent candidate for moderating changes in SERT, 5HT1A, and 5HT2A due to ELS, in the context of the altered eating behavior.

Regarding the dopaminergic system, the DRD1 and DRD2 actively participate in the regulation of food intake, especially with regard to palatable foods, as these are related to the food reward system ([@B45]; [@B8]; [@B80]). Changes in this reward system are linked to eating behavior disorders, with changes in the activity of DRD1 and DRD2 being observed in humans and animals ([@B27]; [@B60]; [@B22]; [@B19]; [@B61]; [@B69]). In addition, both receptors are modulated by ELS ([@B19]; [@B69]). Interestingly, we observed that miR-504 targets both DRD1 and DRD2, with their expression being altered by ELS ([@B93]). Additionally, DRD1 has also been identified as a target for miR-16 ([@B87]). Thus, we believe that miR-504 and miR-16 modulate DRD1 and DRD2, in the context of eating disorders associated with ELS.

In summary, according to the evidence reported, we can infer that the serotonergic and dopaminergic systems undergo regulation of their activity through post-transcriptional modulation by miRNAs. Both systems participate in the physiological and pathological processes of eating behavior, which leads us to believe that miRNAs may be behind several changes in eating behavior as observed in several disorders such as obesity. Several studies point out that the genesis of these disorders is largely associated with experiences of stress early in life. Neonatal stress is already well described as a modulator of the serotonergic and dopaminergic systems associated with disorders of eating behavior, as well as a modulator of expression and activity of miRNAs. In addition, we know that miRNAs participate in the pathological processes of several psychiatric disorders. Thus, we establish here a relationship between neonatal stress and the modulation of the serotonergic and dopaminergic systems, through post-transcriptional regulation by miRNAs, as a possible pathophysiological mechanism behind eating behavior disorders. Future studies are needed to investigate this relationship and provide further support for the scientific community in the search for understanding and treatment of pathologies of eating behavior.
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